PPT-Annual Report on Liver Transplantation 2020/21

SLIDE SET Introduction Source Annual Report for Liver Transplantation 201415 NHS Blood and Transplant Source Annual Report on Liver Transplantation 202021 NHS Blood and Transplant Source Annual Report for Liver Transplantation 201415 NHS Blood and Transplant. U. nusual Cases. . . . Ahmet. . Gurakar. , MD. . . Johns Hopkins School of Medicine. Medical Director, Liver Transplant Program . Bertus Eksteen. Aspen Woods Clinic and University of Calgary . Canada. Important considerations. Predicting timing to list for transplant. Risk of death without transplant. Year 1 liver transplant mortality 10-12%. Associate Professor of Medicine. Division of . Gastroenterology. /Hepatology. University of Utah Health Sciences Center. Referral for Liver Transplantation Evaluation. Last . Updated: . September . 3. wamu.org Contact UsVisit 4401 Connecticut Avenue, NWWashington, DC 20008Write4400 Massachusetts Avenue, NWWashington, DC 20016-8082Call202-885-1200Emailleadershipcircle@wamu.orgDonatewamu.org/donateC Liver and Intestinal Transplantation Activity. in Australia and New Zealand. Data to 31 December 2019. 15 Liver Transplantation and Cancer. Cancer in liver transplant recipients. Type of liver cancers as a primary diagnosis. Liver and Intestinal Transplantation Activity. in Australia and New Zealand. Data to 31 December 2020. 15 Liver Transplantation and Cancer. Cancer in liver transplant recipients. Type of liver cancers as a primary diagnosis. Jessica Wen, M.D.. The Children’s Hospital of Philadelphia. Nov. 3, 2018. Objectives. P. rimary functions of the liver. I. ndications . for Liver . Transplant. P. rocess of liver transplant evaluation and listing. What will change?. Nancy . Reau. , MD. Chief, Section of Hepatology . Richard B. Capps Chair of Hepatology. Rush University Medical Center. Prioritization of patient care in CLD. Decompensated Cirrhosis and Pre-Transplant. Milan Kinkhabwala, MD. Professor of Surgery . Director of Abdominal Transplantation. Montefiore Einstein Center for Cancer Care. History of Transplant. Understanding of . Alloimmunity. : Medawar et al 1950’s. 1 EFSUMB – Editor: Christoph F. Dietrich Liver Transplantation Fabio Piscaglia 1 MD PhD, Paul Sidhu 2 BSc MBBS MRCP FRCR, Knut Brabrand 3 MD and Alberto Borghi 4 MD PhD 1 Department of Digestive This copy is uncontrolled unless printed on ‘Controlled’ paper(Template Version 07/10/08) Author(s): Kathy Zalewska Page 1 of 24 This Policy replacesPOL195/Copy Number Summary of Significa Statistics and Clinical Research. NHS Blood and Transplant. BLTG Transplant Meeting, September 2022. Outline. Overview. Transplant list. Donor and organ supply. Transplant activity. Transplant outcomes. SOLAR-2. Source: . Manns. M, et al. Lancet Infect Dis. 2016;16:685-97.. Treatment Naïve and Treatment Experienced, Phase 2. Ledipasvir-Sofosbuvir + Ribavirin in Advanced Liver Disease. SOLAR-2: Features. ANNUAL PERFORMANCE PLAN . Joint Meeting: Portfolio Committee . on Basic Education . and Select Committee . on Education and Technology, Sports, Arts and Culture . 5 May . 2020. 1. PRESENTATION. . OUTLINE.